The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Meningococcal Polysaccharide Vaccine Market Research Report 2024
Synopsis
Meningococcal polysaccharide diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria.
The global Meningococcal Polysaccharide Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Meningococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Polysaccharide Vaccine.
Report Scope
The Meningococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Meningococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meningococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Bio-Med
CanSinoBIO
Walvax Biotechnology
Chongqing Zhifei Biological
Chengdu Kanghua Biological Products
Changsheng Biotechnology
CanSinoBIO
Segment by Type
Polysaccharide Meningtitis AC
Meningitis ACYW
Segment by Application
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Meningococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Meningococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Meningococcal polysaccharide diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria.
The global Meningococcal Polysaccharide Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Meningococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Polysaccharide Vaccine.
Report Scope
The Meningococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Meningococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meningococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Bio-Med
CanSinoBIO
Walvax Biotechnology
Chongqing Zhifei Biological
Chengdu Kanghua Biological Products
Changsheng Biotechnology
CanSinoBIO
Segment by Type
Polysaccharide Meningtitis AC
Meningitis ACYW
Segment by Application
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Meningococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Meningococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Meningococcal Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of Meningococcal Polysaccharide Vaccine
1.2 Meningococcal Polysaccharide Vaccine Segment by Type
1.2.1 Global Meningococcal Polysaccharide Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Polysaccharide Meningtitis AC
1.2.3 Meningitis ACYW
1.3 Meningococcal Polysaccharide Vaccine Segment by Application
1.3.1 Global Meningococcal Polysaccharide Vaccine Market Value by Application: (2024-2030)
1.3.2 6 Months-15Year
1.3.3 over 3 Year
1.3.4 over 2 Year
1.3.5 over 3 Months
1.4 Global Meningococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Meningococcal Polysaccharide Vaccine Revenue 2019-2030
1.4.2 Global Meningococcal Polysaccharide Vaccine Sales 2019-2030
1.4.3 Global Meningococcal Polysaccharide Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Meningococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Meningococcal Polysaccharide Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Meningococcal Polysaccharide Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meningococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meningococcal Polysaccharide Vaccine, Product Type & Application
2.7 Meningococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.7.1 Meningococcal Polysaccharide Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Meningococcal Polysaccharide Vaccine Players Market Share by Revenue
2.7.3 Global Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Meningococcal Polysaccharide Vaccine Retrospective Market Scenario by Region
3.1 Global Meningococcal Polysaccharide Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Meningococcal Polysaccharide Vaccine Global Meningococcal Polysaccharide Vaccine Sales by Region: 2019-2030
3.2.1 Global Meningococcal Polysaccharide Vaccine Sales by Region: 2019-2024
3.2.2 Global Meningococcal Polysaccharide Vaccine Sales by Region: 2025-2030
3.3 Global Meningococcal Polysaccharide Vaccine Global Meningococcal Polysaccharide Vaccine Revenue by Region: 2019-2030
3.3.1 Global Meningococcal Polysaccharide Vaccine Revenue by Region: 2019-2024
3.3.2 Global Meningococcal Polysaccharide Vaccine Revenue by Region: 2025-2030
3.4 North America Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 North America Meningococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Meningococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.4.3 North America Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.5.1 Europe Meningococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Meningococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.5.3 Europe Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Meningococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Meningococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Latin America Meningococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Meningococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Meningococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Meningococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Meningococcal Polysaccharide Vaccine Sales by Type (2019-2030)
4.1.1 Global Meningococcal Polysaccharide Vaccine Sales by Type (2019-2024)
4.1.2 Global Meningococcal Polysaccharide Vaccine Sales by Type (2025-2030)
4.1.3 Global Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Meningococcal Polysaccharide Vaccine Revenue by Type (2019-2030)
4.2.1 Global Meningococcal Polysaccharide Vaccine Revenue by Type (2019-2024)
4.2.2 Global Meningococcal Polysaccharide Vaccine Revenue by Type (2025-2030)
4.2.3 Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Meningococcal Polysaccharide Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Meningococcal Polysaccharide Vaccine Sales by Application (2019-2030)
5.1.1 Global Meningococcal Polysaccharide Vaccine Sales by Application (2019-2024)
5.1.2 Global Meningococcal Polysaccharide Vaccine Sales by Application (2025-2030)
5.1.3 Global Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Meningococcal Polysaccharide Vaccine Revenue by Application (2019-2030)
5.2.1 Global Meningococcal Polysaccharide Vaccine Revenue by Application (2019-2024)
5.2.2 Global Meningococcal Polysaccharide Vaccine Revenue by Application (2025-2030)
5.2.3 Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Meningococcal Polysaccharide Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Meningococcal Polysaccharide Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Bio-Med
6.2.1 Bio-Med Corporation Information
6.2.2 Bio-Med Description and Business Overview
6.2.3 Bio-Med Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bio-Med Meningococcal Polysaccharide Vaccine Product Portfolio
6.2.5 Bio-Med Recent Developments/Updates
6.3 CanSinoBIO
6.3.1 CanSinoBIO Corporation Information
6.3.2 CanSinoBIO Description and Business Overview
6.3.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Product Portfolio
6.3.5 CanSinoBIO Recent Developments/Updates
6.4 Walvax Biotechnology
6.4.1 Walvax Biotechnology Corporation Information
6.4.2 Walvax Biotechnology Description and Business Overview
6.4.3 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product Portfolio
6.4.5 Walvax Biotechnology Recent Developments/Updates
6.5 Chongqing Zhifei Biological
6.5.1 Chongqing Zhifei Biological Corporation Information
6.5.2 Chongqing Zhifei Biological Description and Business Overview
6.5.3 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product Portfolio
6.5.5 Chongqing Zhifei Biological Recent Developments/Updates
6.6 Chengdu Kanghua Biological Products
6.6.1 Chengdu Kanghua Biological Products Corporation Information
6.6.2 Chengdu Kanghua Biological Products Description and Business Overview
6.6.3 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product Portfolio
6.6.5 Chengdu Kanghua Biological Products Recent Developments/Updates
6.7 Changsheng Biotechnology
6.6.1 Changsheng Biotechnology Corporation Information
6.6.2 Changsheng Biotechnology Description and Business Overview
6.6.3 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product Portfolio
6.7.5 Changsheng Biotechnology Recent Developments/Updates
6.8 CanSinoBIO
6.8.1 CanSinoBIO Corporation Information
6.8.2 CanSinoBIO Description and Business Overview
6.8.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Product Portfolio
6.8.5 CanSinoBIO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meningococcal Polysaccharide Vaccine Industry Chain Analysis
7.2 Meningococcal Polysaccharide Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meningococcal Polysaccharide Vaccine Production Mode & Process
7.4 Meningococcal Polysaccharide Vaccine Sales and Marketing
7.4.1 Meningococcal Polysaccharide Vaccine Sales Channels
7.4.2 Meningococcal Polysaccharide Vaccine Distributors
7.5 Meningococcal Polysaccharide Vaccine Customers
8 Meningococcal Polysaccharide Vaccine Market Dynamics
8.1 Meningococcal Polysaccharide Vaccine Industry Trends
8.2 Meningococcal Polysaccharide Vaccine Market Drivers
8.3 Meningococcal Polysaccharide Vaccine Market Challenges
8.4 Meningococcal Polysaccharide Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Meningococcal Polysaccharide Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Meningococcal Polysaccharide Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Meningococcal Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Meningococcal Polysaccharide Vaccine Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Meningococcal Polysaccharide Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Meningococcal Polysaccharide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Meningococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Meningococcal Polysaccharide Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Meningococcal Polysaccharide Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Meningococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Polysaccharide Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Meningococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Meningococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (K Doses)
Table 18. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Meningococcal Polysaccharide Vaccine Sales by Region (2025-2030) & (K Doses)
Table 20. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Meningococcal Polysaccharide Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Meningococcal Polysaccharide Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Meningococcal Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Meningococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Doses)
Table 27. North America Meningococcal Polysaccharide Vaccine Sales by Country (2025-2030) & (K Doses)
Table 28. North America Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Meningococcal Polysaccharide Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Meningococcal Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Meningococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Meningococcal Polysaccharide Vaccine Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Meningococcal Polysaccharide Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Meningococcal Polysaccharide Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Meningococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Meningococcal Polysaccharide Vaccine Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Meningococcal Polysaccharide Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Meningococcal Polysaccharide Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Meningococcal Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Meningococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Meningococcal Polysaccharide Vaccine Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Meningococcal Polysaccharide Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Meningococcal Polysaccharide Vaccine Sales (K Doses) by Type (2019-2024)
Table 51. Global Meningococcal Polysaccharide Vaccine Sales (K Doses) by Type (2025-2030)
Table 52. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Meningococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2019-2024)
Table 59. Global Meningococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2025-2030)
Table 60. Global Meningococcal Polysaccharide Vaccine Sales (K Doses) by Application (2019-2024)
Table 61. Global Meningococcal Polysaccharide Vaccine Sales (K Doses) by Application (2025-2030)
Table 62. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Meningococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2019-2024)
Table 69. Global Meningococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Sanofi Meningococcal Polysaccharide Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Bio-Med Corporation Information
Table 76. Bio-Med Description and Business Overview
Table 77. Bio-Med Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Bio-Med Meningococcal Polysaccharide Vaccine Product
Table 79. Bio-Med Recent Developments/Updates
Table 80. CanSinoBIO Corporation Information
Table 81. CanSinoBIO Description and Business Overview
Table 82. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. CanSinoBIO Meningococcal Polysaccharide Vaccine Product
Table 84. CanSinoBIO Recent Developments/Updates
Table 85. Walvax Biotechnology Corporation Information
Table 86. Walvax Biotechnology Description and Business Overview
Table 87. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product
Table 89. Walvax Biotechnology Recent Developments/Updates
Table 90. Chongqing Zhifei Biological Corporation Information
Table 91. Chongqing Zhifei Biological Description and Business Overview
Table 92. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product
Table 94. Chongqing Zhifei Biological Recent Developments/Updates
Table 95. Chengdu Kanghua Biological Products Corporation Information
Table 96. Chengdu Kanghua Biological Products Description and Business Overview
Table 97. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product
Table 99. Chengdu Kanghua Biological Products Recent Developments/Updates
Table 100. Changsheng Biotechnology Corporation Information
Table 101. Changsheng Biotechnology Description and Business Overview
Table 102. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product
Table 104. Changsheng Biotechnology Recent Developments/Updates
Table 105. CanSinoBIO Corporation Information
Table 106. CanSinoBIO Description and Business Overview
Table 107. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. CanSinoBIO Meningococcal Polysaccharide Vaccine Product
Table 109. CanSinoBIO Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Meningococcal Polysaccharide Vaccine Distributors List
Table 113. Meningococcal Polysaccharide Vaccine Customers List
Table 114. Meningococcal Polysaccharide Vaccine Market Trends
Table 115. Meningococcal Polysaccharide Vaccine Market Drivers
Table 116. Meningococcal Polysaccharide Vaccine Market Challenges
Table 117. Meningococcal Polysaccharide Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Meningococcal Polysaccharide Vaccine
Figure 2. Global Meningococcal Polysaccharide Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Meningococcal Polysaccharide Vaccine Market Share by Type in 2023 & 2030
Figure 4. Polysaccharide Meningtitis AC Product Picture
Figure 5. Meningitis ACYW Product Picture
Figure 6. Global Meningococcal Polysaccharide Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Meningococcal Polysaccharide Vaccine Market Share by Application in 2023 & 2030
Figure 8. 6 Months-15Year
Figure 9. over 3 Year
Figure 10. over 2 Year
Figure 11. over 3 Months
Figure 12. Global Meningococcal Polysaccharide Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Meningococcal Polysaccharide Vaccine Market Size (2019-2030) & (US$ Million)
Figure 14. Global Meningococcal Polysaccharide Vaccine Sales (2019-2030) & (K Doses)
Figure 15. Global Meningococcal Polysaccharide Vaccine Average Price (US$/Dose) & (2019-2030)
Figure 16. Meningococcal Polysaccharide Vaccine Report Years Considered
Figure 17. Meningococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2023
Figure 18. Global Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Meningococcal Polysaccharide Vaccine Players: Market Share by Revenue in 2023
Figure 20. Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Meningococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2030)
Figure 23. North America Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2030)
Figure 27. Europe Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2030)
Figure 28. Germany Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2019-2030)
Figure 35. China Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Latin America Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Meningococcal Polysaccharide Vaccine by Type (2019-2030)
Figure 56. Global Revenue Market Share of Meningococcal Polysaccharide Vaccine by Type (2019-2030)
Figure 57. Global Meningococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2019-2030)
Figure 58. Global Sales Market Share of Meningococcal Polysaccharide Vaccine by Application (2019-2030)
Figure 59. Global Revenue Market Share of Meningococcal Polysaccharide Vaccine by Application (2019-2030)
Figure 60. Global Meningococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2019-2030)
Figure 61. Meningococcal Polysaccharide Vaccine Value Chain
Figure 62. Meningococcal Polysaccharide Vaccine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
